Modulation of aryl hydrocarbon receptor (AHR) and the NAD(+)-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)

DSpace Repository

Modulation of aryl hydrocarbon receptor (AHR) and the NAD(+)-consuming enzyme CD38: Searches of therapeutic options for nonalcoholic fatty liver disease (NAFLD)

Author: Bock, Karl Walter
Tübinger Autor(en):
Bock, Karl Walter
Published in: Biochemical Pharmacology (2020), Bd. 175, Article UNSP 113905
Verlagsangabe: Pergamon - Elsevier Science Ltd
Language: English
Full text: http://dx.doi.org/10.1016/j.bcp.2020.113905
ISSN: 1873-2968
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)